Washington, D.C., July 16, 2018 – The Alliance for Aging Research submitted comments in response to the Trump administration’s Blueprint to Lower Drug Prices and Reduce Out-of-Pocket (OOP) Costs, which aims to reduce prescription drug prices and modify Medicare Part D, which provides prescription drug coverage to older adults.
Find a full copy of the comments here.
About the Alliance for Aging Research:
The Alliance for Aging Research is the leading nonprofit organization dedicated to accelerating the pace of scientific discoveries and their application to vastly improve the universal human experience of aging and health. The Alliance was founded in 1986 in Washington, D.C., and has since become a valued advocacy organization and a respected influential voice with policymakers. For more information, please visit www.agingresearch.org.
Lauren Smith Dyer
Vice President of Communications